Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
Overview of attention for article published in New England Journal of Medicine, August 2019
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Mentioned by
- news
- 79 news outlets
- blogs
- 2 blogs
- policy
- 2 policy sources
- 80 X users
- patent
- 9 patents
- 5 Facebook pages
- wikipedia
- 3 Wikipedia pages
- 1 Redditor
- f1000
- 1 research highlight platform
- guideline
- 3 clinical guideline sources
Readers on
- mendeley
- 416 Mendeley